Skip to main
ALAB

ALAB Stock Forecast & Price Target

ALAB Analyst Ratings

Based on 17 analyst ratings
Buy
Strong Buy 41%
Buy 41%
Hold 18%
Sell 0%
Strong Sell 0%

Bulls say

Astera Labs Inc has reported significantly higher revenue alongside improved gross margins, which suggests strong operational efficiency despite increased operating expenses. The company is benefiting from a faster than expected build-out of AI infrastructure, resulting in increased server shipments and solid growth in both its Aries and Taurus product lines, demonstrating a robust demand for its advanced solutions. With a projected revenue of $249 million for 4Q25, reflecting an 8% quarter-on-quarter increase and a 76.5% year-on-year growth, Astera Labs is positioned as a high-growth player in the semiconductor industry, supported by a strong demand for its products in AI-driven applications.

Bears say

Astera Labs Inc's revenue growth is heavily reliant on the pace of data center infrastructure spending, making it vulnerable to macroeconomic slowdowns in capital investment. The company's non-GAAP operating expenses for the quarter, recorded at $70.7 million, were below the estimated $74.0 million, suggesting potential challenges in cost management and operational efficiency. These factors collectively contribute to a negative outlook on Astera Labs's stock performance, as they indicate exposure to broader economic risks and potential operational weaknesses.

ALAB has been analyzed by 17 analysts, with a consensus rating of Buy. 41% of analysts recommend a Strong Buy, 41% recommend Buy, 18% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Astera Labs Inc and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Astera Labs Inc (ALAB) Forecast

Analysts have given ALAB a Buy based on their latest research and market trends.

According to 17 analysts, ALAB has a Buy consensus rating as of Jan 7, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $185.71, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $185.71, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Astera Labs Inc (ALAB)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.